Two Hedge Funds Poised to Benefit From a SPAC Deal Worth $1.6 Billion
Sarissa and Perceptive stands to benefit from Pear Therapeutics’ merger with Pritzker-backed blank check company.
The IPO market for new blank check companies may have all but dried up for some time.
But existing SPACs continue to make deals. And two hedge fund firms figure to be significant beneficiaries in the latest announced merger. Thimble Point Acquisition Corp.,